President Trump introduced “TrumpRx” in February to provide Americans with prescription medications at lower prices, similar to those in other developed countries. The author, who has struggled with asthma, shares a personal experience where a medication that costs $600 in the U.S. was only 30 euros in Italy, highlighting the disparity in drug pricing. Despite using a generic version now, the author emphasizes the urgent need for reform in the U.S. pharmaceutical pricing system. Trump has initiated efforts to implement most-favored-nation pricing through deals with pharmaceutical companies to address this issue.
Loading PerspectiveSplit analysis...
